Stockreport

Aelis Farma Reports 2025 Half-Year Financial Results and Presents Progress and Development Outlook [Yahoo! Finance]

Indivior PLC - Ordinary Shares  (INDV) 
PDF cannabis use disorders (CUD) with the CB -SSi AEF0117, which further validated the new pharmacological class of CB -SSi by confirming the compound's safety and its abili [Read more]